Investigating the cell's response to changes in oxygen levels has become a central goal for cancer researchers, as low-oxygen conditions play a role in the resistance of tumors to radiation and chemotherapy, and are also critical in stimulating blood vessel growth.1 Scientists studying the genes and proteins involved in oxygen response pathways are increasingly seeking reliable ways to control sample environments.
To facilitate this research, Biotrace International, headquartered in Wales